Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 214 for “"Cdk2"”.

  1. ANALYSIS OF CDK2 FUNCTION DURING MEIOSIS

    Cyclin-dependent kinase 2 (CDK2) is an absolute requirement for meiotic division. In mouse models lacking CDK2 or CDK2-associated activity, germ cell development is arrested during prophase I of the first meiotic division. In this thesis, I investigate whether CDK2 shows functionality as a …

    nus Repository record for ANALYSIS OF CDK2 FUNCTION DURING MEIOSIS (opens in a new tab) Download file for ANALYSIS OF CDK2 FUNCTION DURING MEIOSIS (opens in a new tab)

  2. Adenovirus-induced cyclin E activates CDK2 for virus replication.

    … the interaction of cyclin E with its partner CDK2 in Ad-infected cells. We show four lines of evidence indicating the importance of CDK2 activation by cyclin E in Ad replication. First, the replication of E1 B55K-deleted Ads was partially inhibited in the transgenic CHO cell line expressing a …

    louisville Repository record for Adenovirus-induced cyclin E activates CDK2 for virus replication. (opens in a new tab)

  3. Cyclin A-Cdk2 inhibition by p21, p27, and p57

    … (determined by absorbance) and cyclin A-Cdk2 of known activity (calibrated with staurosporine), we find that a 1:1 molar ratio of p21 to cyclin A-Cdk2 is able to inhibit Cdk2 activity both in the binary cyclin A-Cdk2 com plex and in the presence of proliferating cell nuclear antigen …

    colostate Repository record for Cyclin A-Cdk2 inhibition by p21, p27, and p57 (opens in a new tab)

  4. Development of Allosteric Inhibitors against Cyclin-dependent Kinase 2 (CDK2)

    Cyclin-dependent kinase 2 (CDK2) is a validated therapeutic target for male nonhormonal contraception as well as various anticancer indications. Despite this, selectively targeting CDK2 has been challenging, largely due to the structural homology of the active site among kinases that most developed …

    umn Repository record for Development of Allosteric Inhibitors against Cyclin-dependent Kinase 2 (CDK2) (opens in a new tab)

  5. Allostery governs Cdk2 activation and differential recognition of CDK inhibitors

    … the activation process of the G1/S kinase Cdk2 in solution. We show that catalytically inactive Cdk2 readily adopts multiple active-like states for efficient dephosphorylation, and that regulatory phosphorylation on the activation loop enhances allosteric coupling with the cyclin subunit. …

    umn Repository record for Allostery governs Cdk2 activation and differential recognition of CDK inhibitors (opens in a new tab)

  6. Preclinical evaluation of a novel CDK2 inhibitor as a potential cancer therapy

    … is designed to inhibit the kinase activity of CDK2, a key driver of cancer cell growth. AU8-18 slowed tumour growth in animal models of ovarian and colorectal cancer and was well tolerated. Its mechanism of action involved halting cell division and inducing cancer cell death. AU8-18 showed …

    adelaide Repository record for Preclinical evaluation of a novel CDK2 inhibitor as a potential cancer therapy (opens in a new tab)

  7. Design, synthesis, and evaluation of novel CDK2 inhibitors as potential anticancer agents

    … of small molecule Cyclin Dependent Kinase-two (CDK2) inhibitors for the treatment of cancer. His research led to the discovery and development of two novel series of compounds. The findings revealed that relatively small molecules derived from 5/6-aminoindazole, and more particularly …

    adelaide Repository record for Design, synthesis, and evaluation of novel CDK2 inhibitors as potential anticancer agents (opens in a new tab)

  8. Preclinical evaluation of novel dual CDK2/5 inhibitors as anticancer drug candidates

    … kinases, namely cyclin dependent kinase 2 and 5 (CDK2/5), important for the proliferation and survival of cancer cells. It is hundred-fold more selective for CDK2/5 over about 374 other kinase enzymes important for normal cellular function. Its encouraging safety and systemic exposure after oral …

    adelaide Repository record for Preclinical evaluation of novel dual CDK2/5 inhibitors as anticancer drug candidates (opens in a new tab)

  9. Expression der Zellzyklusregulatorgene Cyclin A, Cyclin B1, p16 und cdk2 beim Ovarialkarzinom

    … Überexpression von Cyclin A, Cyclin B1, p16 und cdk2 beim Ovarialkarzinom im Zusammenhang mit den Prognosefaktoren Histologie, Grading, Stadium und Tumorrest steht und Einfluss auf Gesamtüberleben und rezidivfreies Überleben hat. Im Kollektiv kann der Einfluss klinischer Prognosefaktoren auf das …

    fu-berlin Repository record for Expression der Zellzyklusregulatorgene Cyclin A, Cyclin B1, p16 und cdk2 beim Ovarialkarzinom (opens in a new tab)

  10. Regulation of Ciz1 by Cyclin A-Cyclin Dependent Kinase 2 (CDK2) mediated phosphorylation

    … the regulation of the protein Ciz1 by cyclin A-CDK2. Ciz1 promotes localisation of cyclin A-CDK2 to chromatin sites at the G1/S phase transition and this ternary complex promotes initiation of DNA replication. However, the mechanisms by which Ciz1 is regulated are not fully understood. Here, …

    lancaster Download PDF for Regulation of Ciz1 by Cyclin A-Cyclin Dependent Kinase 2 (CDK2) mediated phosphorylation (opens in a new tab)

  11. Molecular and biochemical characterisation of phosphorylation-dependent NICD1 turnover: novel roles for CDK1 and CDK2

    In the developing vertebrate embryo, segmentation initiates very early and in a species-specific manner through the formation of somites, which later give rise to the vertebral column, most skeletal musculature and dermis. Somites are gradually and periodically pinched off from the anterior end of …

    dundee Repository record for Molecular and biochemical characterisation of phosphorylation-dependent NICD1 turnover: novel roles for CDK1 and CDK2 (opens in a new tab)

  12. The Role of CDK2 and CDK9 in the Radiation Response of human HNSCC Cancer Cells

    … damage repair, we hypothesised that targeting of CDK2 and CDK9 modifies cancer cell response to radiotherapy. Therefore, we evaluated the significance of CDK2 and CDK9 for the cellular radiation response in a panel of human head and neck squamous cell carcinoma (HNSCC) cell lines. In order to …

    qucosa-diss

  13. The Application of X-ray Crystallography towards the Design of Novel Inhibitors of MurA and CDK2

    … than the inhibitors discovered in this work. CDK2 plays a critical role in the G1- to S-phase checkpoint of the cell cycle. Only a few drugs targeting CDK2 are in clinical trials, thus there is a need for the discovery of novel CDK2 inhibitors. Six CDK2 inhibitor scaffolds were identified by …

    ku Repository record for The Application of X-ray Crystallography towards the Design of Novel Inhibitors of MurA and CDK2 (opens in a new tab)

  14. Derivatives of 4-(1H-pyrazol-4-yl)pyrimidine CDK2 inhibitors as potential anticancer agents : design, synthesis & evaluation

    Cyclin dependent kinase 2 (CDK2) is a serine/threonine protein kinase that plays an important role in regulating various facets of the cell division cycle. Deregulation of CDK2 and its activating partners is associated with a myriad of human tumours and resistance to anticancer drugs. Thus, CDK2 …

    adelaide Repository record for Derivatives of 4-(1H-pyrazol-4-yl)pyrimidine CDK2 inhibitors as potential anticancer agents : design, synthesis & evaluation (opens in a new tab)

  15. Characterization of the molecular mechanisms underlying retinoic acid induced growth inhibition in MCF-7 human breast cancer cells.

    … a down regulation of cyclin dependent kinase 2 (cdk2) and cyclin D1 gene expression and a profound down regulation of cdk2 activity. In contrast, no changes were seen in cdk4 expression or activity. We have further demonstrated that RA did not cause a change in the overall levels of expression of …

    ottawa-retro Repository record for Characterization of the molecular mechanisms underlying retinoic acid induced growth inhibition in MCF-7 human breast cancer cells. (opens in a new tab)

Page 1 of 11